Related references
Note: Only part of the references are listed.Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells
Jay Friedman et al.
CLINICAL CANCER RESEARCH (2020)
Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy
Xiaojing Shi et al.
MOLECULAR THERAPY (2020)
In Situ Photocatalysis of TiO-Porphyrin-Encapsulated Nanosystem for Highly Efficient Oxidative Damage against Hypoxic Tumors
Huaqing Chen et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors
Mikiya Ishihara et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Self-Assembled Nanoparticles Prepared from Low-Molecular-Weight PEI and Low-Generation PAMAM for EGFRvIII-Chimeric Antigen Receptor Gene Loading and T-Cell Transient Modification
Qianru Yu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD 123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment
Dan Guo et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Nanoparticles-mediated reoxygenation strategy relieves tumor hypoxia for enhanced cancer therapy
Hong Wang et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Measurement of NLG207 (formerly CRLX101) nanoparticle-bound and released camptothecin in human plasma
Keith T. Schmidt et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2020)
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
Margaret M. Billingsley et al.
NANO LETTERS (2020)
Combining microenvironment normalization strategies to improve cancer immunotherapy
Fotios Mpekris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Anti-EGFR-Coated Gold Nanoparticles In Vitro Carry 5-Fluorouracil to Colorectal Cancer Cells
Raquel B. Liszbinski et al.
MATERIALS (2020)
Reshaping Tumor Immune Microenvironment through Acidity-Responsive Nanoparticles Featured with CRISPR/Cas9-Mediated Programmed Death-Ligand 1 Attenuation and Chemotherapeutics-Induced Immunogenic Cell Death
Kun Tu et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Phase 2 study of hyper-CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia
Koji Sasaki et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Remodeling of Metastatic Vasculature Reduces Lung Colonization and Sensitizes Overt Metastases to Immunotherapy
Bo He et al.
CELL REPORTS (2020)
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer
Marcus Ruscetti et al.
CELL (2020)
Multifunctional Immunoliposomes Combining Catalase and PD-LI Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma
Yu Hei et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancer
Preethi Korangath et al.
SCIENCE ADVANCES (2020)
Recent Progress on the Versatility of Virus-Like Particles
Ciying Qian et al.
VACCINES (2020)
Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy
Waqas Nawaz et al.
ACTA BIOMATERIALIA (2020)
Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
Jesus Zepeda-Cervantes et al.
FRONTIERS IN IMMUNOLOGY (2020)
Self-Assembled Multivalent Aptamer Nanoparticles with Potential CAR-like Characteristics Could Activate T Cells and Inhibit Melanoma Growth
Chenjun Bai et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Fucoidan-based, tumor-activated nanoplatform for overcoming hypoxia and enhancing photodynamic therapy and antitumor immunity
Chu-Hung Chung et al.
BIOMATERIALS (2020)
High-affinity mutant Interleukin-13 targeted CAR T cells enhance delivery of clickable biodegradable fluorescent nanoparticles to glioblastoma
Gloria B. Kim et al.
BIOACTIVE MATERIALS (2020)
The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma
Lu Chen et al.
THERANOSTICS (2020)
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization (vol 175, pg 313, 2018)
Miguel F. Sanmamed et al.
CELL (2019)
Surface functionalized folate targeted oleuropein nano-liposomes for prostate tumor targeting: In vitro and in vivo activity
Anmar M. Nassir et al.
LIFE SCIENCES (2019)
Antibody-based nanotechnology
Yaron Hillman et al.
NANOTECHNOLOGY (2019)
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
Leonie Voorwerk et al.
NATURE MEDICINE (2019)
Targeted antibody and cytokine cancer immunotherapies through collagen affinity
Jun Ishihara et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Nanoparticles from Cuttlefish Ink Inhibit Tumor Growth by Synergizing Immunotherapy and Photothermal Therapy
Rong-Hui Deng et al.
ACS NANO (2019)
Tumor-specific delivery of gemcitabine with activatable liposomes
Samantha T. Tucci et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
Thomas Yau et al.
JOURNAL OF HEPATOLOGY (2019)
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
Paolo Antonio Ascierto et al.
NATURE MEDICINE (2019)
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
Antoni Ribas et al.
NATURE MEDICINE (2019)
Adverse Events Following Cancer Immunotheraoy: Obstacles and Opportunities
Kristen E. Pauken et al.
TRENDS IN IMMUNOLOGY (2019)
Near-Infrared II Phototherapy Induces Deep Tissue Immunogenic Cell Death and Potentiates Cancer Immunotherapy
Yinchu Ma et al.
ACS NANO (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Hannah Onafuye et al.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2019)
Dopamine Delivery via pH-Sensitive Nanoparticles for Tumor Blood Vessel Normalization and an Improved Effect of Cancer Chemotherapeutic Drugs
Mohammad Taleb et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
Muhammad Zaeem Noman et al.
CELLS (2019)
Herceptin-conjugated paclitaxel loaded PCL-PEG worm-like nanocrystal micelles for the combinatorial treatment of HER2-positive breast cancer
Jiahui Peng et al.
BIOMATERIALS (2019)
T cell immunotherapy enhanced by designer biomaterials
Zachary S. Dunn et al.
BIOMATERIALS (2019)
Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer-study protocol of the FORCE trial
Farastuk Bozorgmehr et al.
BMC CANCER (2019)
CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice
Laboni Mondal et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies
Yun-Chieh Sung et al.
NATURE NANOTECHNOLOGY (2019)
Immune Checkpoint Blockade Mediated by a Small-Molecule Nanoinhibitor Targeting the PD-1/PD-L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer
Rui Zhang et al.
SMALL (2019)
Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by drug combination
Yosi Gilad et al.
SCIENTIFIC REPORTS (2019)
A new drug carrier with oxygen generation function for modulating tumor hypoxia microenvironment in cancer chemotherapy
Zhe Zhang et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Engineered nano-immunopotentiators efficiently promote cancer immunotherapy for inhibiting and preventing lung metastasis of melanoma
Lijia Luo et al.
BIOMATERIALS (2019)
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O'Donnell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
An Oxygen Self-sufficient Fluorinated Nanoplatform for Relieved Tumor Hypoxia and Enhanced Photodynamic Therapy of Cancers
Shengnan Ma et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells
Qian Chen et al.
ADVANCED MATERIALS (2019)
Host immune response to anti-cancer camptothecin conjugated cyclodextrin-based polymers
Yi-Fan Chen et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
S. K. Daniel et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2019)
Modulating tumor hypoxia by nanomedicine for effective cancer therapy
Rana Jahanban-Esfahlan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Normalizing Tumor Microenvironment Based on Photosynthetic Abiotic/Biotic Nanoparticles
Diwei Zheng et al.
ACS NANO (2018)
A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy
Yu Mi et al.
ADVANCED MATERIALS (2018)
Delivery of small interfering RNA against Nogo-B receptor via tumor-acidity responsive nanoparticles for tumor vessel normalization and metastasis suppression
Bin Wang et al.
BIOMATERIALS (2018)
Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumors
Hyesun Hyun et al.
BIOMATERIALS (2018)
Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
Kristian M. Hargadon et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Maturation of dendritic cells in vitro and immunological enhancement of mice in vivo by pachyman- and/or OVA-encapsulated poly(D, L-lactic acid) nanospheres
Sisi Zheng et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells
Heng Dong et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Leakage kinetics of the liposomal chemotherapeutic agent Doxil: The role of dissolution, protonation, and passive transport, and implications for mechanism of action
Luisa M. Russell et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy
Chih-Sheng Chiang et al.
NATURE NANOTECHNOLOGY (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole
P. A. Pacheco et al.
PARASITOLOGY RESEARCH (2018)
Complete Local and Abscopal Responses from a Combination of Radiation and Nivolumab in Refractory Hodgkin's Lymphoma
Qian Qin et al.
RADIATION RESEARCH (2018)
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
Wantong Song et al.
NATURE COMMUNICATIONS (2018)
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis et al.
CANCER DISCOVERY (2018)
Oxygen-generating Hybrid Polymeric Nanoparticles with Encapsulated Doxorubicin and Chlorin e6 for Trimodal Imaging-Guided Combined Chemo-Photodynamic Therapy
DanRong Hu et al.
THERANOSTICS (2018)
Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al2O3 nanoparticles
Wenfei Chen et al.
THERANOSTICS (2018)
CAR-T Cells Surface-Engineered with Drug-Encapsulated Nanoparticles Can Ameliorate Intratumoral T-cell Hypofunction
Natnaree Siriwon et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Identifying and managing the adverse effects of immune checkpoint blockade
Arthur Winer et al.
JOURNAL OF THORACIC DISEASE (2018)
Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy
Jinrong Peng et al.
ADVANCED SCIENCE (2018)
Tumor Oxygenation and Hypoxia Inducible Factor-1 Functional Inhibition via a Reactive Oxygen Species Responsive Nanoplatform for Enhancing Radiation Therapy and Abscopal Effects
Lingtong Meng et al.
ACS NANO (2018)
Harnessing albumin as a carrier for cancer therapies
Ella N. Hoogenboezem et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Gold nanoparticles-mediated photothermal therapy and immunotherapy
Yang Liu et al.
IMMUNOTHERAPY (2018)
Immune-related adverse events from combination immunotherapy in cancer patients: A comprehensive meta-analysis of randomized controlled trials
Bo Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
L. Horn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Porous Gold Nanoshells on Functional NH2-MOFs: Facile Synthesis and Designable Platforms for Cancer Multiple Therapy
Chuang Liu et al.
SMALL (2018)
Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles
Zaigang Zhou et al.
THERANOSTICS (2018)
Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
Sandro Matosevic
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
High-Dose Vincristine Sulfate Liposome Injection, for Advanced, Relapsed, or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in an Adolescent and Young Adult Subgroup of a Phase 2 Clinical Trial
Gary J. Schiller et al.
JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY (2018)
A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma
Jennifer L. McQuade et al.
BMC CANCER (2018)
Virus-Like Particles as Carrier Systems to Enhance Immunomodulation in Allergen Immunotherapy
Martina Anzaghe et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2018)
Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
Kaitlin Graham et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
Priyamvada Jayaprakash et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
Frank Stephen Hodi et al.
LANCET ONCOLOGY (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Perfluorocarbon Nanoparticles Mediated Platelet Blocking Disrupt Vascular Barriers to Improve the Efficacy of Oxygen-Sensitive Antitumor Drugs
Zaigang Zhou et al.
SMALL (2018)
Targeting antigen-presenting cells by anti-PD-1 nanoparticles augments antitumor immunity
Farideh Ordikhani et al.
JCI INSIGHT (2018)
Gold nanoparticles attenuate metastasis by tumor vasculature normalization and epithelial-mesenchymal transition inhibition
Wei Li et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Simple nanoliposomes encapsulating Lycium barbarum polysaccharides as adjuvants improve humoral and cellular immunity in mice
Ruonan Bo et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
Jacob Schachter et al.
LANCET (2017)
Supportive care for patients undergoing immunotherapy
Bernardo Leon Rapoport et al.
SUPPORTIVE CARE IN CANCER (2017)
Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers
H. F. Moffett et al.
NATURE COMMUNICATIONS (2017)
Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
Guizhi Zhu et al.
NATURE COMMUNICATIONS (2017)
Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancer
Joseph Chao et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)
Tumor vasculature normalization by orally fed erlotinib to modulate the tumor microenvironment for enhanced cancer nanomedicine and immunotherapy
Qian Chen et al.
BIOMATERIALS (2017)
Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages
Yuan Qian et al.
ACS NANO (2017)
Initial Evaluation of the Safety of Nanoshell-Directed Photothermal Therapy in the Treatment of Prostate Disease
Joshua M. Stern et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2016)
Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles
Sin-Tzu Ning et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy
Panpan Zhang et al.
CANCER SCIENCE (2016)
Management of toxicities of immune checkpoint inhibitors
Lavinia Spain et al.
CANCER TREATMENT REVIEWS (2016)
Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment
Jeremiah L. Oyer et al.
CYTOTHERAPY (2016)
The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy
Frank C. Passero et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Photo-thermal therapy of bladder cancer with Anti-EGFR antibody conjugated gold nanoparticles
Chieh Hsiao Chen et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2016)
PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery
Hyunah Cho et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
Corey J. Langer et al.
LANCET ONCOLOGY (2016)
Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer
Paul E. Hughes et al.
TRENDS IN IMMUNOLOGY (2016)
Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine
David B. Page et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines
Takashi Nakamura et al.
SCIENTIFIC REPORTS (2016)
Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy
Karlo Perica et al.
ACS NANO (2015)
Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
L. Apetoh et al.
ANNALS OF ONCOLOGY (2015)
Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer
Seong Ho Choi et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ovarian Cancer Immunotherapy Using PD-L1 siRNA Targeted Delivery from Folic Acid-Functionalized Polyethylenimine: Strategies to Enhance T Cell Killing
Pei Yun Teo et al.
ADVANCED HEALTHCARE MATERIALS (2015)
Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory t cells
Wei Ye et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Effect of nanovaccine chemistry on humoral immune response kinetics and maturation
Shannon L. Haughney et al.
NANOSCALE (2014)
Structure-based programming of lymph-node targeting in molecular vaccines
Haipeng Liu et al.
NATURE (2014)
Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
Laura Jeanbart et al.
CANCER IMMUNOLOGY RESEARCH (2014)
In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes
Yiran Zheng et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Molecular Pathways: Hypoxia Response in Immune Cells Fighting or Promoting Cancer
Asis Palazon et al.
CLINICAL CANCER RESEARCH (2012)
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
Christoph Mamot et al.
LANCET ONCOLOGY (2012)
Hypoxia promotes tumor growth in linking angiogenesis to immune escape
Salem Chouaib et al.
FRONTIERS IN IMMUNOLOGY (2012)
Autophagy-assisted antigen cross-presentation Autophagosome as the argo of shared tumor-specific antigens and DAMPs
Yongxiang Yi et al.
ONCOIMMUNOLOGY (2012)
Antiangiogenic properties of silver nanoparticles
Sangiliyandi Gurunathan et al.
BIOMATERIALS (2009)
HER2-specificT-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan
Shigehisa Kitano et al.
CLINICAL CANCER RESEARCH (2006)
Share Paper
